| Distinction of lymphoid and myeloid clonal hematopoiesis A Niroula, A Sekar, MA Murakami, M Trinder, M Agrawal, WJ Wong, ... Nature medicine 27 (11), 1921-1927, 2021 | 211 | 2021 |
| Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis PG Kim, A Niroula, V Shkolnik, M McConkey, AE Lin, M Słabicki, JP Kemp, ... Journal of Experimental Medicine 218 (12), 2021 | 123 | 2021 |
| Clonal haematopoiesis and risk of chronic liver disease WJ Wong, C Emdin, AG Bick, SM Zekavat, A Niroula, JP Pirruccello, ... Nature 616 (7958), 747-754, 2023 | 118 | 2023 |
| Measurable residual disease monitoring in acute myeloid leukemia with t (8; 21)(q22; q22. 1): results from the AML Study Group FG Rücker, M Agrawal, A Corbacioglu, D Weber, S Kapp-Schwoerer, ... Blood, The Journal of the American Society of Hematology 134 (19), 1608-1618, 2019 | 115 | 2019 |
| Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial P Paschka, RF Schlenk, D Weber, A Benner, L Bullinger, M Heuser, ... Leukemia 32 (7), 1621-1630, 2018 | 113 | 2018 |
| TET2-mutant clonal hematopoiesis and risk of gout M Agrawal, A Niroula, P Cunin, M McConkey, V Shkolnik, PG Kim, ... Blood, The Journal of the American Society of Hematology 140 (10), 1094-1103, 2022 | 111 | 2022 |
| MDR1 expression predicts outcome of Ph+ chronic phase CML patients on second-line nilotinib therapy after imatinib failure M Agrawal, B Hanfstein, P Erben, D Wolf, T Ernst, A Fabarius, S Saussele, ... Leukemia 28 (7), 1478-1485, 2014 | 30 | 2014 |
| Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia LD Weeks, CR Marinac, R Redd, G Abel, A Lin, M Agrawal, RM Stone, ... Blood, The Journal of the American Society of Hematology 139 (8), 1246-1250, 2022 | 27 | 2022 |
| Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis PG Miller, AS Sperling, CJ Gibson, K Viswanathan, C Castellano, ... Blood, The Journal of the American Society of Hematology 136 (26), 3051-3055, 2020 | 25 | 2020 |
| Understanding the German health care system K Obermann, P Müller, HH Müller, B Schmidt, B Glazinski Mannheim Institute of Public Health, 2013 | 24 | 2013 |
| Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation AE Lin, AC Bapat, L Xiao, A Niroula, J Ye, WJ Wong, M Agrawal, ... Circulation 149 (18), 1419-1434, 2024 | 21 | 2024 |
| Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t (8; 21)(q22; q22): a study of the German-Austrian AML Study Group N Jahn, M Agrawal, L Bullinger, D Weber, A Corbacioglu, VI Gaidzik, ... Leukemia 31 (4), 1012-1015, 2017 | 20 | 2017 |
| Identification of germline variants in adults with hemophagocytic lymphohistiocytosis PG Miller, A Niroula, JJ Ceremsak, CJ Gibson, MS Taylor, S Birndt, ... Blood Advances 4 (5), 925-929, 2020 | 19 | 2020 |
| International electives in the final year of German medical school education–a student's perspective D Ebrahimi-Fakhari, M Agrawal, L Wahlster GMS Zeitschrift für Medizinische Ausbildung 31 (3), Doc26, 2014 | 18 | 2014 |
| Minimal residual disease monitoring in acute myeloid leukemia (AML) with translocation t (8; 21)(q22; q22): results of the AML Study Group (AMLSG) M Agrawal, A Corbacioglu, P Paschka, D Weber, VI Gaidzik, N Jahn, ... Blood, The Journal of the American Society of Hematology 128 (22), 1207-1207, 2016 | 17 | 2016 |
| CDK4/6 inhibitor palbociclib for treatment of KMT2A-rearranged acute myeloid leukemia: interim analysis of the AMLSG 23-14 trial S Fröhling, M Agrawal, N Jahn, LR Fransecky, CD Baldus, R Wäsch, ... Blood 128 (22), 1608, 2016 | 16 | 2016 |
| Sustained remission and reversal of end-organ dysfunction in a patient with anaplastic myeloma M Agrawal, J Kanakry, CA Arnold, DL Suzman, L Mathieu, YL Kasamon, ... Annals of hematology 93, 1245-1246, 2014 | 12 | 2014 |
| Association of Somatic TET2 Mutations With Giant Cell Arteritis ML Robinette, LD Weeks, RJ Kramer, M Agrawal, CJ Gibson, Z Yu, ... Arthritis & Rheumatology 76 (3), 438-443, 2024 | 7 | 2024 |
| Clonal evolution of FLT3-ITD positive AML in patients treated with midostaurin in combination with chemotherapy within the ratify (CALGB 10603) and AMLSG 16-10 trials LK Schmalbrock, S Cocciardi, A Dolnik, M Agrawal, F Theis, N Jahn, ... Blood 130, 182, 2017 | 6 | 2017 |
| Somatic TET2 Mutations are Associated with Giant Cell Arteritis ML Robinette, LD Weeks, RJ Kramer, M Agrawal, CJ Gibson, Z Yu, ... medRxiv, 2023.07. 26.23292945, 2023 | 4 | 2023 |
